Allogene Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Allogene Therapeutics, Inc. has filed 570 SEC EDGAR filings since 19 Apr 2018

SEC filing history

Showing 101-125 of 570 matching filings.

Per page
25
Current page
5
144 File 001-38693

144 filing

Filing date
14 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
14 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285781

S-8

Filing date
13 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90685

SCHEDULE 13G/A filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2025
Reporting date
01 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Mar 2025
Reporting date
01 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
18 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90685

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90685

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90685

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90685

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .